/People

Sylvia Fong

Investor

Scientific Advisory Group Member at Pathway to Cures

Canada

Find your path to Sylvia

Sign up to see every warm intro you have to Sylvia

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Sylvia. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Fong is an independent consultant and Adjunct Associate Professor at Queen's University specializing in gene therapy. With over 25 years of R&D experience, she pioneered the first approved AAV-based gene therapy for hemophilia A at BioMarin.

Colleagues at Pathway to Cures

Frequently asked questions

Who is Sylvia Fong?
Fong is an independent consultant and Adjunct Associate Professor at Queen's University specializing in gene therapy. With over 25 years of R&D experience, she pioneered the first approved AAV-based gene therapy for hemophilia A at BioMarin.
Where does Sylvia Fong work?
Sylvia Fong is Scientific Advisory Group Member at Pathway to Cures.

About this profile. Compiled from public sources — Pathway to Cures's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights